Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
L.M.X.4 is a topical anesthetic cream containing 4% lidocaine, used for local analgesia. In a clinical trial conducted by Vanderbilt University Medical Center (NCT04766684), it is being studied in combination with a saline injection (delivered via the J-Tip needle-free system) as a comparator arm for pain management in infants undergoing percutaneous Achilles tenotomy for clubfoot. Lidocaine works by blocking voltage-gated sodium channels, preventing the conduction of nerve impulses and providing localized pain relief. This specific protocol evaluates the efficacy of the topical cream against needle-free lidocaine injections to optimize pain control in neonatal orthopedic procedures.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on L.M.X.4 cream + saline injection.